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The first ever venous thrombotic condition associated with spaceflight, an internal jugular vein thrombus requiring anticoagulation, has re-
cently been reported. Systematic investigation of space travel-associated thrombotic risk has not been conducted. Cellular, animal, and
human studies performed in ground-based models and in actual weightlessness revealed influences of weightlessness and gravity on the
blood coagulation system. However, human study populations were small and limited to highly selected participants. Evidence in individu-
als with medical conditions and older persons is lacking. Evidence for thrombotic risk in spaceflight is unsatisfactory. This issue deserves
further study in heterogeneous, high risk populations to find prevention strategies and to enable safe governmental and touristic human
spaceflight.
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Introduction
Half a century ago, the first human being set foot on the surface of the
moon. Now, humankind steps up efforts to return to the moon and to
go beyond to other celestial bodies. Moreover, the National
Aeronautics and Space Administration (NASA) recently announced
plans to open the International Space Station (ISS) for touristic space
flight. Several companies in the USA are waiting in the wings to offer
suborbital flights to paying customers. Previously, space was accessible
to few carefully selected and highly trained individuals. In the near future,
persons not meeting all these medical and psychological requirements
will have the chance to travel to space. In this optimistic atmosphere,
potential risks of space travel should not be neglected. Deep leg vein
thrombosis following airplane travel, the so-called economy class syn-
drome, received much attention years ago. Now, a report on internal
jugular vein thrombosis in astronauts in space,1,2 an unusual thrombotic
site on ground,3 has startled the space medical community.
The medical problem
The complex human haemostatic system evolved under terrestrial
conditions.4 The system is crucial for rapid bleeding control, im-
mune defence, and wound healing. The human coagulation system
comprises the three columns endothelial function, platelet-,
leucocyte-, and microparticle-driven cellular clotting, and plasmat-
ic coagulation. Malfunction of one or more of these columns may
cause life-threatening medical conditions like spontaneous bleed-
ing, myocardial infarction, stroke, pulmonary embolisms, or im-
mune dysfunction.
Spaceflight causes blood stasis in the upper body
Stasis of blood flow, one of the components of the classical Virchow
triad, increases thrombosis risk (Take home figure). During long-term
missions to the ISS, ultrasound revealed grossly dilated internal jugu-
lar veins in resting astronauts. On average, internal jugular diameter
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.was 9.8 mm2 while seated on Earth and 70.3 mm2 onboard ISS. The
finding is unexpected given the substantial reduction of invasively
measured central venous pressure in weightlessness.5 However, in-
ternal jugular vein pressure and volume increased approximately
three- and four-fold in acute weightlessness, respectively.6,7 In add-
ition to chronic cranial venous hypervolaemia and hypertension,
strenuous physical tasks in weightlessness are likely to produce peaks
in venous pressure and wall stress. Veins under pressure respond
with remodelling and inflammation of their walls and with endothelial
dysfunction.8 Interestingly, venous wall biomechanics at higher trans-
mural pressures show relevant inter-individual differences.9 The ven-
ous network of the upper body was not designed to store large
amount of blood over a long duration which may result in structural
and functional failure6 and increased thrombogenicity. Altered rib-
cage shape in weightlessness, ribs are more upwards and vertical ori-
ented, may lead to a Paget-Schroetter-like, spaceflight-associated
venous obstruction syndrome.10
Six out of 11 astronauts showed static or reversed blood flow
in the right internal jugular vein. In terrestrial medicine, the
phenomenon is seen in patients with severe tricuspid valve insuffi-
ciency. One astronaut developed clinically silent thrombosis of the
internal jugular vein discovered on flight day 50. Following this in-
cidental finding an internal jugular vein mass was retrospectively
discovered on the ultrasound images of a second astronaut.2 The
first astronaut was anticoagulated according to current ESC guide-
lines for the management of deep vein thrombosis11 adapted to
the unique spaceflight context.1 Possibly, venous congestion of the
head and lung embolism, driven by a headward shift of 2000 mL
blood and extracellular volume in weightlessness,12 could pose a
serious health risk in professional and recreational astronauts. The
high impact forces imposed on the returning capsule at ground
contact could conceivably dislodge preformed venous thrombi,
thus, provoking embolic events.
Blood coagulability and rheology is altered in space
Blood hypercoagulability in space is mainly driven by haemoconcen-
tration (Take home figure). After an initial increase in central blood
volume when entering weightlessness, reduced thirst and increased
Take home figure Proposed mechanisms of thrombus formation in space. The space environment is characterized by a unique combination of
interacting prothrombotic factors. Several of them fall in more than one of the pathophysiological categories of the Virchow’s triad. CA, carotid ar-
tery; Gz, force of weight acting in head-to-foot direction; IJV, internal jugular vein; P, pressure; T, shear stress.
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urine output13 lead to intravascular volume contraction. The mecha-
nisms contributes to relative increases in fibrinogen levels and ele-
vated red blood cell and platelet counts.14 While the distribution of
red blood cell morphologies in peripheral blood was changed in
astronauts on the Skylab space station, in vitro red cell aggregation of
blood samples from healthy donors and from patients with cardiovas-
cular disease was lower on the space shuttle compared to ground.15
Spaceflight is associated with triggers of vascular
endothelial dysfunction
During spaceflight, astronauts may experience vascular endothelial
dysfunction for different reasons (Take home figure). Mild homocystei-
naemia, with its potentially toxic effects on the blood clotting cascade
and on vascular endothelium, increases thrombo-embolic risk.16 Due
to genetic predisposition, some astronauts show altered 1-carbon-
metabolism resulting in mild homocysteinaemia in space.17 Radiation
induced vascular damage through DNA double strand breaks, oxida-
tive stress, and inflammation18 could become particularly relevant
during exploration missions to the moon and Mars.19 Chronic stasis
and dilation of the upper body venous network may lead to shedding
of the intravascular microlayer, which restrains coagulation at vascu-
lar interface.20 Aging individuals are increasingly assigned to commer-
cial and professional spaceflight missions. Aging is associated with
alterations of vascular endothelial function21 and an increased throm-
botic risk.22 A low-grade chronic inflammatory state due to muscle
tissue wasting23 and altered immune function in space,24 accompa-
nied by chronically increased body temperature,25 could also affect
the vascular endothelium. Spaceflight specific atmospheric threats,
like hypobaric decompression stress during extravehicular activity,26
hyperoxia or hypoxia of future lunar and Martian habitats,27 may lead
to endothelial dysfunction. Finally, high levels of psychosocial stress
related to confinement,28 lack of natural light,29 chronic time shift-
ing,30 and disturbed sleep31 may perturb the vascular endothelium
and jeopardize the vulnerable haemostasic balance.
Given the importance of the haemostatic system for human sur-
vival, it is surprising that weightlessness has been overlooked as
thrombotic risk factor for over half of a century. Many physiological
circuits including cardiovascular, pulmonary, and musculoskeletal sys-
tems have been intensively investigated in space and in terrestrial
space analogues. However, human blood coagulation and rheology
have been somewhat neglected. Nevertheless, the idea that space-
flight could impact human coagulation has long been postulated.
Inflight evidence for thrombotic risk
As far as we know, clinically apparent thromboembolic events have
not been described in astronauts. A cranial magnetic resonance imag-
ing (MRI) study in 27 astronauts, designed to detect thrombotic
masses of the cerebral and ocular veins did not depict any thrombotic
condition after landing.32 Moreover, decades of vascular ultrasound
experiments aboard the Russian space station MIR and ISS did not re-
veal thrombotic structures.6 However, ultrasound is highly operator
dependent and particularly challenging under space conditions.
Moreover, techniques that are applied to detect thrombi during
ultrasound scans, particularly venous compression, have not been
routinely applied. Finally, the ultrasound scans on ISS only covered
selected venous segments for physiological analysis rather than clinic-
al thrombus detection.
Thus far, only 565 highly selected individuals travelled to space
spending overall 150 man-years under spaceflight conditions. This
relatively small group may not be sufficient to gauge the incidence of
thrombo-embolic events in space. Thus, reliable estimates of
spaceflight-associated thrombotic risk cannot be ascertained. For
comparison, the risk for thrombotic events on Earth is age-
related.22,33 In individuals 25–30 years old—the average age of the
US astronauts is in their forties—the risk for venous thrombosis is
approximately 1:10 000/year.33 In comparison, passengers of long dis-
tance airline flights develop symptomatic, or silent venous throm-
bosis and pulmonary embolism, respectively, on 1 per 4600 flights.34
Strenuous space flight missions have previously been associated
with serious cardiovascular events in astronauts pointing towards
enhanced thrombus formation and inflammation.35 The first day in
space and the return day, which are particularly challenging, are asso-
ciated with signs of an acute phase stress response, which is known
to promote blood coagulation.36–38 These mission phases are, how-
ever, dominated by the multiple stresses imposed by launch and land-
ing. Accordingly, space shuttle astronauts showed transient increases
in fibrinogen synthesis rate on landing day39 and on the first day in
space likely caused by a metabolic stress response.40 Whether this in-
crease represents only a short lasting elevation of fibrinogen concen-
tration or an actual coagulation activation with clinical implications, is
unknown. Increased orthostatic stress following return to Earth may
have contributed to the response.41 Further spaceflight-associated
conditions, like sustained immobilization in the narrow Russian
Cheget cosmonaut chair during taxi flights to the ISS could conceiv-
ably increase the risk for haemostatic imbalance. Haemoconcentra-
tion accompanied by an increased platelet count, which could
promote thrombosis, has been documented for long-duration mis-
sions aboard ISS.14 Coagulation protein expression, in particular the
fibrinogen beta chain, was changed in cosmonauts after long-term
spaceflight but recovered within 1 week after return to Earth.42 The
majority of US female astronauts take oral contraceptives for cycle
suppression during their space mission, which would double their
risk of sustaining deep venous thrombosis on Earth. However, this
risk calculation may not be simply transferable to their stay in
space.43
Evidence from human ground-based
models
Bedrest studies in the -6 head-down position are commonly applied
as ground-based analogues for weightlessness. The approach models
musculoskeletal and cardiovascular decondition, and volume shifts
observed in space. Reduced red blood cell deformability and
increased aggregation have been reported in such studies.44 Yet,
platelet activation was reduced.45 6 head-down bedrest led to an in-
crease in fibrinogen concentration without clinically relevant changes
in blood coagulation capacity.46 Thrombelastographic clotting times
point rather towards an extenuated coagulation during chronic bed-
rest47 which is in line with the fact that singular stasis has been ques-
tioned as general thrombotic risk factor.48 Though, orthostatic stress
during reambulation was associated with a significant shift towards
hypercoagulopathy pointing towards an increased risk for
Thrombosis and space flight 3
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thrombotic events after the end of bed rest.49 Increased hydrostatic
pressure and shear stress in the maladapted vessels50 of the lower
body likely induce endothelial cell-based activation of coagulation.4 In
addition to intact haematological cells, gravity-driven effects on cell
fragments, so-called microparticles, could affect haemostasis.
Circulating endothelial microparticles, a sign of endothelial dysfunc-
tion, were increased during dry immersion, which is another ground-
based analogue for weightlessness.51
Evidence from animal and cell models
Data from animal and cell models on influences of real or simulated
spaceflight related conditions on haemostasis is scarce. The models
show a relevant influence of gravity on cellular haemostasis in the
sense that hypergravity augments and reduced gravity attenuates
blood coagulation.52–55
Conclusions and clinical outlook
Internal jugular vein thrombosis in 2 out of 11 astronauts is unexpect-
ed.2 Yet, whether and to what degree spaceflight puts astronauts at an
increased thrombotic risk cannot be ascertained. Data from ground-
based studies are not conclusive. Given the potential for life-
threatening complications and limited access to medical care in space,
thrombotic risks associated with spaceflight should be assessed soon
to protect the health of professional and recreational astronauts.
As far as we know, systematic testing for hereditary or acquired
thrombophilia risk factors is currently neither part of the European
astronaut selection processes nor is it yet recommended for commer-
cial space flight. Thus, individuals with risk factors for thrombophilia
may fly into space. The validity of thrombophilia screening as part of
the commercial astronaut selection should be re-evaluated in the light
of the recent thrombotic reports from space. Thrombosis of the jugu-
lar internal vein, as recently reported in two astronauts on the ISS, is
uncommon on ground but has been reported as the primary repre-
sentation of thrombophilia. Moreover, strenuous exercise with the
upper extremities, unpreventable during life in weightlessness, is a
known risk factor for thrombotic events of the upper body so-called
effort thrombosis.56 In general, thrombotic events of the upper parts
of the body may develop more often in weightlessness compared to
ground. In any case, systematic, robust data on global effects of space
flight on human haemostasis are still lacking but are now urgently
needed. Technical limitations hamper the success of this kind of study.
For example, point of care testing techniques like viscoelastic methods
(e.g. thrombelastometry, thrombelastography) and evaluation of
platelet function (e.g. aggregometry) are technically not feasible in
weightlessness. Furthermore coagulation testing is extremely suscep-
tible for error and, both, adequate sample storage in space and safe
sample return to Earth are substantial challenges.
Preventive and therapeutic approaches for spaceflight-associated
thrombosis have not yet been tested. Mechanistic studies are required
to guide such interventions. Lower body negative pressure could
serve as countermeasure for venous stasis thereby lowering throm-
botic risk in weightlessness. However, severe orthostatic challenges
could promote thrombotic risk.4 Whether and how spaceflight-
associated thrombosis requires treatment such as therapeutic anticoa-
gulation is unknown. Potential benefits on thrombus formation have
to be weighed against increased bleeding risk which is difficult to man-
age onboard a spacecraft. Manned space exploration and commercial
space flight require comprehensive understanding of human haemo-
stasis in space to provide safer surgical procedures, adequate wound
healing, and thrombo-embolic prevention, especially in older astro-
nauts and individuals with relevant pre-existing conditions.
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